Researchers decode the evolutionary pathway of regulatory proteins

Aerovate Ther­a­peu­tics’ mid-stage treat­ment for pul­monary ar­te­r­i­al hy­per­ten­sion failed to mean­ing­ful­ly im­prove pa­tients’ blood pres­sure com­pared to place­bo across three dos­es, send­ing the com­pa­ny’s shares

The FDA on Thurs­day ap­proved Phath­om Phar­ma­ceu­ti­cals’ potas­si­um-com­pet­i­tive acid block­er Vo­quez­na (vono­prazan) to treat ero­sive gas­troe­sophageal re­flux dis­ease (GERD), of­fer­ing a new class of treat­ment